Diabetes treatment is constantly advancing, with new therapeutic options appearing to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the https://fayphoy288048.tusblogos.com/39496513/emerging-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment